Shu-Yuan Xiao to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Shu-Yuan Xiao has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.024
-
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence. Cancer Discov. 2011 Dec; 1(7):573-9.
Score: 0.024